Arizona’s healthcare innovation economy is accelerating. The FDA’s recent clearance of transcranial magnetic stimulation for adolescents with major depressive disorder positions the state as a national leader in next-generation mental health technology and opens a new reimbursable market for behavioral health providers statewide.
TMS is a non-invasive, non-drug treatment that uses magnetic pulses to stimulate underactive brain regions associated with depression. Long approved for adults, the new federal clearance for teens marks a pivotal shift in behavioral-health delivery. With coverage now expanding to younger patients, the approval strengthens one of Arizona’s fastest-growing medical sectors and supports a more sustainable care model.
“Insurers too often act as gatekeepers. This FDA approval dismantles that barrier,” said Dr. Houshang Aminian, MD, Medical Director at American TMS Clinics. “Adolescents who have not responded to therapy or medication, or who cannot tolerate side effects, now have access to a treatment that is safe, non-invasive, and evidence-based.”
Arizona’s health-tech ecosystem, from Scottsdale to Chandler, is emerging as a hub for data-driven behavioral therapies. With adolescent TMS now covered by major insurers, providers are scaling, investors are watching, and employers are beginning to quantify the economic value of improved youth mental health.
Arizona’s mental-health need is significant. More than 1.3 million adults and about 139,000 teens in the state experience depression or another mental-health condition each year. Yet more than 2 million Arizonans live in areas with too few mental-health professionals, and the state ranks near the bottom nationally for access to care. Expanding coverage for non-drug treatments like TMS offers both a public-health solution and a major growth opportunity for Arizona’s behavioral-health market.
The FDA’s approval for adolescent brain-stimulation therapy broadens coverage to a new demographic and reinforces Arizona’s growing neuromodulation sector. Major insurers are beginning to reimburse treatment for teens, lowering out-of-pocket costs to standard co-pays and improving accessibility statewide. The decision arrives as demand for behavioral-health services continues to rise in Arizona’s fastest-growing counties, creating both clinical and economic opportunity. Early, effective intervention can help reduce long-term costs across healthcare, education, and workforce productivity, while local providers such as American TMS Clinics—offering both adolescent and adult care—are positioned to scale and strengthen Arizona’s leadership in the behavioral-health market.
For Arizona’s healthcare economy, this access translates to measurable impact. Clinics such as American TMS are expanding staff, investing in infrastructure, and strengthening referral networks as insurance coverage extends to younger patients. Employers across the state also benefit: better mental health access means reduced absenteeism, higher school and work participation, and stronger family stability.
“TMS does more than mask symptoms. It restores function to the brain,” said Juliane Popelka, CEO of American TMS Clinics. “For Arizona’s economy, that means fewer crises, stronger families, and more productive communities. Mental health access is as much an economic issue as it is a clinical one.”
At the clinic level, American TMS integrates 20-channel EEG brain mapping to track patient progress, a data-driven approach that resonates with both payers and providers. Its dual focus on adolescent and adult patients reinforces continuity of care and cements its role as a scalable model in Arizona’s innovation economy.
“This is a long-fought milestone,” added Dr. Aminian. “Insurers can no longer hide behind red tape. These kids deserve care, and we are ready to deliver it.”
